Pediatric Outpatient Prescriptions in Countries With Advanced Economies in the 21st Century
Authors:
Open Access
- 25 April 2022
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 5 (4) , e225964
Abstract
The World Health Organization (WHO) defines rational drug prescribing as appropriate medicines in adapted doses for an adequate period of time.1 In Organisation for Economic Co-operation and Development (OECD) member countries,2 where drugs are reimbursed by health insurance schemes for large parts of the population, irrational drug prescribing may be frequent, especially for outpatient prescriptions.1,3,4 The pediatric population, notably the youngest children, should be prioritized for monitoring irrational outpatient drug use because of developmental immaturity and a lower level of evaluation of drugs compared with the adult population, despite the introduction of new regulations.5 Indeed, several severe rare or long-term adverse effects were found for drugs used at high rates in pediatrics.6-10 Furthermore, encounters between the pediatric population and potential prescribers are frequent in the first years of life because of numerous symptoms and self-limited diseases.11,12 Irrational prescribing may vary among countries by primary care physicians’ initial and continuous education,4 parental health literacy and attitudes toward drugs,3,13 drug regulatory authority policies,14 and health system characteristics.15 Because epidemiological patterns of the main pediatric diseases are similar in countries with advanced economies,16 comparing the prevalence of pediatric outpatient prescriptions (POPs) among these countries may reveal substantial discrepancies regarding inadequate practices at the national scale and may guide corrective actions.17Keywords
This publication has 70 references indexed in Scilit:
- Understanding physician antibiotic prescribing behaviour: a systematic review of qualitative studiesInternational Journal of Antimicrobial Agents, 2013
- Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreementJournal of Clinical Epidemiology, 2012
- Drug use in children: cohort study in three European countriesBMJ, 2008
- Conditional reimbursement within the Dutch drug policyHealth Policy, 2007
- Identifying how age and gender influence prescription drug use in a primary health care environment in Catalonia, SpainBritish Journal of Clinical Pharmacology, 2007
- Rational prescribing for childrenBMJ, 2006
- Drug utilization statistics for individual-level pharmacy dispensing dataPharmacoepidemiology and Drug Safety, 2005
- The prevalence of symptoms and consultations in pre-school children in the Avon Longitudinal Study of Parents and Children (ALSPAC): a prospective cohort studyFamily Practice, 2005
- Has the ‘Therapeutic Orphan’ Finally Been Adopted?The Journal of Pediatric Pharmacology and Therapeutics, 2003
- Phenobarbital for Febrile Seizures — Effects on Intelligence and on Seizure RecurrenceNew England Journal of Medicine, 1990